Summary The intensity and degree of heterogeneous epithelial marker expression were evaluated immunohistochemically in 29 mucosal biopsy specimens from 7 ulcerative colitis (UC) patients with dysplasia. Biopsy specimens from UC patients with mild (n =7) or severe (n= 6) inflammation and from histologically normal samples (n=7) served as controls. HLA-DR showed heterogeneous epithelial expression in all lesions with high grade dysplasia and in 6 of 8 with low grade dysplasia. SC was heterogeneously stained in 17 of 21 lesions with high grade dysplasia and in all but two lesions with low grade dysplasia. In histologically normal mucosa, SC was homogeneously expressed and epithelial DR was virtually absent. In mildly inflamed UC lesions, SC exhibited patchy distribution in only one sample and DR in two, whereas both SC and DR showed a slight degree of heterogeneous expression in all lesions with severe inflammation. Moreover, the overall intensity of SC staining tended to decrease with increasing degree of inflammation, whereas the opposite was seen for DR. Decreased SC and increased DR expression thus seemed to be related to intensified inflammatory activity, whereas heterogeneous expression of these markers was significantly more related to dysplasia.
Patients with long-standing total ulcerative colitis (UC) are at increased risk for developing large bowel carcinomas (Lennard-Jones et al., 1983) . It is generally accepted that this risk is related to high grade epithelial dysplasia. All patients with long-standing UC should be subjected to regular biopsy sampling from the various segments of the large bowel to select those who would benefit from prophylactic proctocolectomy (Vatn et al., 1984) .
Epithelial dysplasia of the large bowel epithelium is often difficult to evaluate because inflammation and crypt destruction result in regenerative alterations which may imitate those found in genuine dysplasia (Riddel et al., 1983) . Many attempts have been made to find markers of a truly dysplastic development, but conclusive evidence to this end has yet to be presented (Issacson, 1976; 1982; Rognum et al., 1982a; Boland et al., 1984; Hammarberg et al., 1984; Shields et at., 1985; Ehsanullah et al., 1985; Jass et al., 1986) .
It seems justified to continue the search for objective criteria of dysplasia. The purpose of the present investigation was to evaluate epithelial expression of class II (HLA-DR) determinants and secretory component (SC) in lesions of UC by means of immunohistochemistry. The idea was that phenotypic characteristics might reflect genotypic alterations typical for dysplastic epithelium.
Materials and methods
Patients and tissue samples Forty two colonic biopsy specimens from 13 patients with long-standing ulcerative colitis were examined immunohistochemically with regard to epithelial expression of HLA-DR determinants and SC. The mucosal specimens were taken at random, but well away from the tumour in cases with carcinoma. Clinico-pathological information about these patients is given in Table I 
Immunohistochemical procedures
The tissue specimens were fixed in cold 96% ethanol and processed for paraffin embedding as described previously (Brandtzaeg, 1974) . Serial sections (6 um) were dewaxed and subjected to paired immunofluorescence staining at room temperature. One section from each series was stained by a trichrome routine method (HAS) containing haematoxylin, azofloxine, and safron (Stave & Brandtzaeg, 1977) . Another section was first incubated for 30 min with a tetramethylrhodamine isothiocyanate (TRITC)-labelled sheep IgG anti SC; its optical density (OD) ratio (280 nm/SlS nm) was 1.7 and its working concentration 0.64 g IgG 1 - (Rognum et al., 1980) . Thereafter a murine monoclonal antibody to a nonpolymorphic HLA-DR determinant (Beckton Dickinson, Sunnyvale, Calif., USA) was applied (1:20 for 20 h) in a three-step immunofluorescence method 200W lamp for excitation of TRITC (red emission) and with an XBO 150 W lamp for FITC (green emission). Narrowband excitation and selective filtration of the fluorescence colours were obtained with a Ploem-type epi-illuminator. The epithelial staining for HLA-DR and SC was scored semiquantitatively on arbitrary scales from 0 to 3. DRpositive cells showed usually diffuse fluorescence throughout the cytoplasm with peripheral intensification, particularly apically in glandular structures. A score of 0 was given for virtually no staining, I for faint peripheral staining with extension into the cytoplasm, and 3 for intense overall fluorescence. Details about the scoring of SC staining are given elsewhere (Rognum et al., 1980) . The same investigator was responsible for the fluorescence evaluation throughout the study without knowing the histological diagnosis. A blind test for reproducibility in a previous study did not reveal any systematic error (Rognum et al., 1980) .
The distribution of the SC and DR staining was, in addition, separately categorized as heterogeneous (extensive, intermediate or slight) or homogeneous. An extensive degree of heterogeneous staining refers to the presence of abrupt transition between positive and negative epithelium (Rognum et al., 1982b .
The adjacent HAS-stained sections were evaluated blindly by another pathologist throughout the study. Dysplasia was graded as high-grade or low-grade according to the standardized classification of Riddell et al. (1983) . Biopsy samples showing overt inflammation, crypt destruction and epithelial regeneration were not evaluated with regard to dysplasia (Yardley & Keren, 1974) . The degree of 
Statistical analyses
Comparisons between sample groups with regard to fluorescence scores and degree of heterogeneous expression were based on the one-tailed Mann-Whitney U test.
Results
High grade dysplastic lesions were found in 21 biopsy samples, whereas 8 were assigned to the low grade dysplasia group. Seven biopsy samples with regenerative changes showed a mild degree of inflammation whereas six showed a severe degree (Table I) .
In normal large bowel mucosa the staining for SC was evenly distributed throughout the columnar epithelial cells with intensification along the luminal border, whereas there was virtually no or only very faint staining for HLA-DR determinants (Figures 2, 5 and 6 ).
In the group of samples with inflammatory changes (but with no sign of dysplasia) the staining intensity for SC tended to decrease with increasing degree of inflammation whereas the opposite was noted for HLA-DR (Figures 3 and  5 (Rognum et al., 1982a) . The presence of sulphated mucopolysaccharides, binding of peanut agglutinin or differences in the nuclear DNA content have likewise turned out to be of no diagnostic value (Jass et al., 1986; Hammarberg et al., 1984) . Furthermore, a significantly weaker expression of SC in dysplastic compared with regenerative lesions is not applicable in diagnostic work because of large individual variations (Rognum et al., 1 982a) .
In the present study we showed that dysplastic lesions expressed both HLA-DR and SC in a more heterogeneous pattern than those with regenerative epithelial changes. Extensive heterogeneity was seen especially in high-grade dysplasia and might be due to the presence of several different neoplastic cell clones with variable ability to express the two epithelial markers. Such phenotypic differences between clones within the same lesion might reflect early cancer development as proposed by Nowell (1976; 1986) . According to his theory, tumour progression is explained by an acquired genetic lability permitting increasingly altered subpopulations with new characteristics. In this context it is interesting that the HLA-DR expression in dysplastic UC lesions resembled that seen in well-differentiated large-bowel carcinomas .
The increase in HLA-DR expression noted with increasing degree of inflammation was in accordance with previous findings (Selby et al., 1983; Poulsen et al., 1986; Moore et al., 1986; McDonald & Jewell, 1987) . Such aberrant DR expression might reflect immunological activity since DR production may be induced by y-interferon -a lymphokine released from activated T-cells (Pober et al., 1983) . Moreover, the evenly distributed expression of both DR and SC in UC without dysplasia, was similar to that seen in the 'transitional mucosa' adjacent to carcinomas (Rognum et al., 1982c; Moore et al., 1986) . This might be of interest as the mucosa in this zone, as in the UC lesions, contains dense infiltrates of lymphoid cells and macrophages (Svennevig, 1980; Rognum et al., 1979) . SC expression in ulcerative colitis was significantly reduced compared with normal (Rognum et al., 1982a) , and tended to decrease with increasing inflammatory activity. This finding might seem to contrast with the observations of yinterferon-induced SC expression in a colon carcinoma cell line and of increased SC expression in inflammatory lesions in gastric mucosa (Valnes et al., 1984) and salivary glands (Thrane et al., personal communication) . However, in UC the secretory epithelium may be under particular influence by as yet undefined factors which lead to down-regulation of SC expression. Moreover, decreased SC expression does not necessarily imply impaired production but may reflect enhanced secretion rate (Hamilton et al., (1980) .
Since samples showing overt inflammatory changes were not evaluated with regard to dysplasia (Yardley & Keren, 1974) , we believe that the observed heterogeneous expression of HLA-DR might reflect epithelial genotypic heterogeneity rather than varying microenvironmental influences on the epithelium. The similarities in distribution pattern of DR determinants in dysplastic UC lesions and in most large bowel carcinomas (Daar et al., 1982 (Daar et al., ,1983 Rognum et al., 1983; Ghosh et al., 1986; Moore et al., 1986) , indicate that this feature is phenotypic for early malignant development in large bowel epithelium. This hypothesis is further strengthened by the observation that similar heterogeneity is seen in large bowel adenomas (Rognum et al., unpublished observation) . The possibility that the present finding might turn out to be helpful in a diagnostic context remains to be tested in a larger, prospective follow-up study.
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